Palatin Technologies, Inc. (PTN)
10.76
+0.77
(+7.71%)
USD |
NASDAQ |
Sep 01, 12:01
Palatin Technologies Cash from Operations (TTM) : -14.93M for March 31, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -14.93M |
| December 31, 2025 | -15.87M |
| September 30, 2025 | -15.91M |
| June 30, 2025 | -21.31M |
| March 31, 2025 | -23.69M |
| December 31, 2024 | -26.94M |
| September 30, 2024 | -32.57M |
| June 30, 2024 | -31.46M |
| March 31, 2024 | -34.59M |
| December 31, 2023 | -27.40M |
| September 30, 2023 | -26.60M |
| June 30, 2023 | -29.27M |
| March 31, 2023 | -27.38M |
| December 31, 2022 | -35.47M |
| September 30, 2022 | -32.08M |
| June 30, 2022 | -29.92M |
| March 31, 2022 | -30.74M |
| December 31, 2021 | -24.75M |
| September 30, 2021 | -32.88M |
| June 30, 2021 | -22.65M |
| March 31, 2021 | -20.19M |
| December 31, 2020 | -19.20M |
| September 30, 2020 | -9.698M |
| June 30, 2020 | 41.33M |
| March 31, 2020 | 40.46M |
| Date | Value |
|---|---|
| December 31, 2019 | 39.16M |
| September 30, 2019 | 38.59M |
| June 30, 2019 | -21.78M |
| March 31, 2019 | -4.344M |
| December 31, 2018 | -7.767M |
| September 30, 2018 | -5.269M |
| June 30, 2018 | 1.703M |
| March 31, 2018 | -21.68M |
| December 31, 2017 | 29.05M |
| September 30, 2017 | 20.92M |
| June 30, 2017 | 12.88M |
| March 31, 2017 | 12.07M |
| December 31, 2016 | -41.65M |
| September 30, 2016 | -44.56M |
| June 30, 2016 | -47.36M |
| March 31, 2016 | -43.14M |
| December 31, 2015 | -38.23M |
| September 30, 2015 | -28.48M |
| June 30, 2015 | -13.36M |
| March 31, 2015 | -8.407M |
| December 31, 2014 | -4.593M |
| September 30, 2014 | -4.437M |
| June 30, 2014 | -12.21M |
| March 31, 2014 | -12.76M |
| December 31, 2013 | -14.53M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Decoy Therapeutics, Inc. | -8.324M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |
| Savara, Inc. | -110.38M |